Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Clinical Research Center, Chiba University Hospital, Chiba, Japan.
Endoscopy. 2018 Jul;50(7):693-700. doi: 10.1055/s-0043-124869. Epub 2018 Feb 7.
Endoscopic resection of all colonic adenomas prevents the occurrence of colon cancer and death. The European Society of Gastrointestinal Endoscopy Clinical Guideline recommends resection of all polyps predicted to be adenomas and cold snare polypectomy (CSP) for removal of adenomas ≤ 9 mm on the basis of safety; however, it also states that this recommendation lacks adequate evidence of efficacy. The residual adenoma rate after resection is an important indicator of efficacy, but there have been no reports showing this prospectively. Therefore, we aimed to investigate the residual adenoma rate after CSP of small colonic polyps.
Between March 2015 and April 2017, patients who were endoscopically diagnosed with colorectal adenomas < 9 mm underwent CSP, the site being marked with endoscopic clips. Patients with pathologically confirmed adenomas underwent follow-up colonoscopy 3 weeks after CSP and any post-CSP scars were biopsied. The primary endpoint was the presence of pathological residual adenoma 3 weeks after CSP.
Overall, 126 lesions in 39 patients were removed and 125 (99.2 %) were resected en bloc using CSP. Pathologically, 111 lesions (88.1 %) were confirmed as adenomas (4.2 ± 1.5 mm), with 36 of these (32.4 %) determined to be R0 resections. No complications were observed. All 37 patients with pathologically confirmed adenomas underwent follow-up colonoscopy, and 102 of 111 scars were detected in 33 patients. One pathological residual adenoma (0.98 %, 95 % confidence interval 0.02 % - 5.3 %) was identified.
CSP appears to be an effective treatment for diminutive and small colorectal adenomas, with a low residual adenoma rate.
内镜下切除所有结直肠腺瘤可预防结肠癌的发生和死亡。欧洲胃肠道内镜学会临床指南建议根据安全性切除所有预测为腺瘤的息肉和冷圈套息肉切除术(CSP)以切除≤9mm 的腺瘤;然而,该指南还指出,这一建议缺乏充分的疗效证据。切除后残留腺瘤率是疗效的一个重要指标,但目前尚无前瞻性报道。因此,我们旨在研究 CSP 治疗小结肠息肉的残留腺瘤率。
2015 年 3 月至 2017 年 4 月,内镜诊断为结直肠腺瘤<9mm 的患者接受 CSP 治疗,并用内镜夹标记部位。病理证实为腺瘤的患者在 CSP 后 3 周行随访结肠镜检查,并对任何 CSP 后瘢痕进行活检。主要终点是 CSP 后 3 周时存在病理残留腺瘤。
共 39 例患者的 126 处病变被切除,125 处(99.2%)采用 CSP 整块切除。病理上,111 处病变(88.1%)证实为腺瘤(4.2±1.5mm),其中 36 处(32.4%)为 R0 切除。未观察到并发症。所有 37 例病理证实为腺瘤的患者均接受了随访结肠镜检查,33 例患者中检测到 111 处瘢痕中的 102 处。发现 1 例(0.98%,95%置信区间 0.02%~5.3%)病理残留腺瘤。
CSP 似乎是治疗小和小结肠腺瘤的有效方法,残留腺瘤率较低。